The eatertainment brand saw same-store sales fall 7.7% last quarter, and failed to maintain a leverage ratio required by a financing covenant.

BTIG analyst Marie Thibault reiterated a Buy rating on Insulet (PODD – Research Report) yesterday and set a price target of $310.00. The ...

In a report released yesterday, Eric Hagen from BTIG maintained a Buy rating on Dynex Capital (DX – Research Report), with a price target of ...

When we spoke three years ago, your research was focused on the shopping center, net lease and health care subsectors. Is there anything new or different about your coverage universe here in 2025? Mr.

Investors attending the conference wishing to schedule a meeting are encouraged to contact BTIG to schedule. Event: BTIG’s MedTech, Digital Health, Life Science & Diagnostic Tools Conference 2025 ...

BTIG Research analyst C. Reichardt now forecasts that the construction company will earn $1.73 per share for the quarter, down from their prior estimate of $1.79. Skip to main content Analyst Ratings ...

On Thursday, BTIG analyst Justin Zelin downgraded Kura Oncology stock (NASDAQ:KURA) from Buy to Neutral. Zelin cited concerns over the recent KOMET-001 study results for the company's drug, ziftomenib ...

announced today that it will participate in the BTIG at Snowbird: MedTech, Digital Health, Life Science & Diagnostic Tools Conference, on Wednesday, February 12th. Rohit Ramchandani, CFO ...